Cochrane · systematic review · CD004541
Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
Palmer, SC, Natale, P, Ruospo, M, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 75%Low 0 · 0%Moderate 1 · 25%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Antidepressant therapy versus placebo for depression in dialysis patients
Population: dialysis patients with depression
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Dizziness or hypotension Antidepressant therapy vs placebo | no estimate extracted | 3 studies · 114 participants | Very low |
Nausea Antidepressant therapy vs placebo | no estimate extracted | 3 studies · 114 participants | Moderate |
Sexual dysfunction Antidepressant therapy vs placebo | no estimate extracted | 2 studies · 101 participants | Very low |
All‐cause mortality Antidepressant therapy vs placebo | no estimate extracted | 1 study · 50 participants | Very low |